Antibody therapy in steroid-resistant rejection

Transplant Proc. 1998 Aug;30(5):1778-9. doi: 10.1016/s0041-1345(98)00428-x.
No abstract available

MeSH terms

  • Antilymphocyte Serum / adverse effects
  • Antilymphocyte Serum / therapeutic use*
  • Chi-Square Distribution
  • Cyclosporine / blood
  • Cyclosporine / therapeutic use
  • Drug Resistance
  • Follow-Up Studies
  • Graft Rejection / drug therapy*
  • Graft Rejection / prevention & control
  • Graft Survival*
  • Humans
  • Immunosuppression Therapy / methods
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / mortality
  • Muromonab-CD3 / adverse effects
  • Muromonab-CD3 / therapeutic use*
  • Retrospective Studies
  • Steroids / therapeutic use
  • Survival Rate
  • Time Factors

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Steroids
  • Cyclosporine